Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy

Nov. 10, 2011 - PRLog -- The global ICD and CRT-D market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 5% over the period 2010–2017 to reach revenue of $9.8 billion by 2017. The growth in this market during the forecast period will be driven by the increase in population of patients with cardiac arrhythmias and Congestive Heart Failure (CHF) conditions and the continued adoption of ICDs and CRT-Ds for their treatment. The demand for continuously evolving technologies in ICDs and CRT-Ds will help sustain the market growth rate. In the forecast period, ICDs are expected to grow at a rate of 5% to reach $5.6 billion by 2017. CRT-Ds are expected to grow at the rate of 6% to reach revenue of $4.2 billion by 2017.

The global ICD and CRT-D market is dominated by Medtronic followed by St. Jude Medical and Boston Scientific Corporation. Medtronic’s ICDs and CRT-Ds business is the largest with revenues accounting for nearly 43% of the global revenues in 2010. St. Jude Medical and Boston Scientific Corporation have market shares of 26% and 23% respectively. BIOTRONIK and Sorin Group also have significant presence in the market.

The increasing incidence rate of cardiovascular diseases and associated heart failures is rapidly expanding the patient pool for cardiac rhythm management devices, and thereby resulting in the growing adoption rates of ICDs and CRT-D. As per the World Health Organization (WHO), it is estimated that by 2030, approximately around 23.6 million people would die from cardiovascular diseases (CVD), mainly from heart diseases and stroke. The risk factors for CVDs include blood pressure, high cholesterol, obesity and use of tobacco. The guidelines from the American Heart Association (AHA) and American College of Cardiology recommend the timely implantation of these devices in Congestive Heart Failure (CHF) patients since they carry significant risk of unexpected cardiac arrhythmias or associated cardiac arrests. The Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) study of heart patients in the US also recommends more attention to chronic heart failures in women and congenital heart defects in children.

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/RequestSamplePages....

The US, with revenue worth $3.9 billion in 2010, is the largest market for ICDs and CRT-Ds. High incidence rate of cardiovascular diseases with substantial risk of Sudden Cardiac Arrest (SCA) is spurring the adoption of ICDs and CRT-Ds. According to the Heart Foundation, SCA is a leading cause of death in the US, accounting for an estimated 325,000 lives in a year. It was also observed that white and African
American people had the highest proportion of SCAs.

According to the Centers for Disease Control and Prevention (CDC), there has been a 10% rise in the number of SCAs over the period 1989-1996 (from 2,719 to 3000 cases).

GlobalData’s new report, “Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market. The report provides market landscape, competitive landscape and market trends information on the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis
by GlobalData’s team of industry experts.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Impl...

Visit our report store: http://www.globaldata.com/reportstore

For more details contact:
pressreleases@globaldata.com
           
North America:    +1 646 395 5477
Europe:        +44 207 753 4299
           +44 1204 543 533
Asia Pacific:       +91 40 6616 6782

# # #

GlobalData is a global market intelligence services company providing information research and analysis products and services.